TSXV:CLAS.H - Post by User
Comment by
PTBaileyon Mar 30, 2022 9:07am
82 Views
Post# 34558326
RE:N.O. in the news, No Clas
RE:N.O. in the news, No ClasRed~One wrote: GeNO recently completed a Phase 2 pilot study of its nitric oxide for use as a diagnostic in Pulmonary Arterial Hypertension (PAH), and the company is currently performing a dose-escalation trial for the Treatment of Pulmonary Hypertension in patients with PAH and Pulmonary Hypertension secondary to Idiopathic Pulmonary Fibrosis (PH-IPF).
This is from an article posted August 9, 2012.
GeNo article This study was completed in Sept of 2016, can you post link to results?